应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DGX 奎斯特诊疗
盘前交易 07-27 05:35:46 EDT
227.86
-0.04
-0.02%
最高
233.21
最低
223.42
成交量
154.21万
今开
228.00
昨收
227.90
日振幅
4.30%
总市值
251.50亿
流通市值
250.65亿
总股本
1.10亿
成交额
3.54亿
换手率
1.40%
流通股本
1.10亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读 | 业绩超预期并上调全年指引,奎斯特诊疗盘中大涨11.54%
异动解读 · 07-23
异动解读 | 业绩超预期并上调全年指引,奎斯特诊疗盘中大涨11.54%
异动解读|奎斯特诊疗盘中上涨8.71%,Q2业绩大幅超预期并再度上调全年指引
行情直击 · 07-23
异动解读|奎斯特诊疗盘中上涨8.71%,Q2业绩大幅超预期并再度上调全年指引
奎斯特诊疗高管:医保定价持平至微幅增长,医院转诊业务定价略降
美股速递 · 07-23
奎斯特诊疗高管:医保定价持平至微幅增长,医院转诊业务定价略降
奎斯特诊疗高管:下半年Nova支出预计占全年总额约70%,此前预期为60%——电话会议透露
美股速递 · 07-23
奎斯特诊疗高管:下半年Nova支出预计占全年总额约70%,此前预期为60%——电话会议透露
奎斯特诊疗高管:ACA交易业务中,医生请求数量减少,但每次请求检测量增多,两者相互抵消——电话会议
美股速递 · 07-23
奎斯特诊疗高管:ACA交易业务中,医生请求数量减少,但每次请求检测量增多,两者相互抵消——电话会议
异动解读|奎斯特诊疗盘前上涨6.28%,Q2财报大幅超预期并上调全年指引
行情直击 · 07-23
异动解读|奎斯特诊疗盘前上涨6.28%,Q2财报大幅超预期并上调全年指引
异动解读 | 财报超预期并上调指引,奎斯特诊疗盘前大涨5.32%
异动解读 · 07-23
异动解读 | 财报超预期并上调指引,奎斯特诊疗盘前大涨5.32%
奎斯特诊疗发布2026年第二季度财报,并上调全年营收与每股收益指引
美股速递 · 07-23
奎斯特诊疗发布2026年第二季度财报,并上调全年营收与每股收益指引
财报前瞻|奎斯特诊疗本季度营收预计增9.09%,机构观点偏积极
财报Agent · 07-16
财报前瞻|奎斯特诊疗本季度营收预计增9.09%,机构观点偏积极
Biovica再获客户订单,累计收获九份工作指令
投资观察 · 07-14
Biovica再获客户订单,累计收获九份工作指令
异动解读 | 奎斯特诊疗盘中大涨5.09%,因第一季度业绩超预期并上调全年指引
异动解读 · 04-21
异动解读 | 奎斯特诊疗盘中大涨5.09%,因第一季度业绩超预期并上调全年指引
奎斯特诊疗CEO透露:60-70%资源投入实验室自动化,AI工具提升诊断准确率与呼叫中心效率
美股速递 · 04-21
奎斯特诊疗CEO透露:60-70%资源投入实验室自动化,AI工具提升诊断准确率与呼叫中心效率
奎斯特诊疗(DGX)盘前涨3.41% 上调2026年全年业绩指引
金吾财讯 · 04-21
奎斯特诊疗(DGX)盘前涨3.41% 上调2026年全年业绩指引
奎斯特诊疗公布2026财年第一季度业绩 上调全年营收与每股收益指引
美股速递 · 04-21
奎斯特诊疗公布2026财年第一季度业绩 上调全年营收与每股收益指引
财报前瞻|奎斯特诊疗本季度营收预计增7.47%,机构观点偏多
财报Agent · 04-14
财报前瞻|奎斯特诊疗本季度营收预计增7.47%,机构观点偏多
异动解读 | 奎斯特诊疗盘中大涨5.09%,受强劲财报、乐观业绩指引及股东回报措施提振
异动解读 · 02-10
异动解读 | 奎斯特诊疗盘中大涨5.09%,受强劲财报、乐观业绩指引及股东回报措施提振
奎斯特诊疗涨4.68% 股价突破200美元大关
市场透视 · 02-10
奎斯特诊疗涨4.68% 股价突破200美元大关
奎斯特诊疗高管确认:基于上周联邦资金法案通过,2026年PAMA将无影响
美股速递 · 02-10
奎斯特诊疗高管确认:基于上周联邦资金法案通过,2026年PAMA将无影响
奎斯特诊疗公布2025年第四季度及全年财报 发布2026年度业绩指引 季度股息上调7.5%至每股0.86美元
美股速递 · 02-10
奎斯特诊疗公布2025年第四季度及全年财报 发布2026年度业绩指引 季度股息上调7.5%至每股0.86美元
奎斯特诊疗季度股息上调7.5%至0.86美元,实现连续十五年增长;同步宣布追加10亿美元股票回购授权
美股速递 · 02-10
奎斯特诊疗季度股息上调7.5%至0.86美元,实现连续十五年增长;同步宣布追加10亿美元股票回购授权
加载更多
公司概况
公司名称:
奎斯特诊疗
所属市场:
NYSE
上市日期:
--
主营业务:
奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。
发行价格:
--
{"stockData":{"symbol":"DGX","market":"US","secType":"STK","nameCN":"奎斯特诊疗","latestPrice":227.86,"timestamp":1784923200000,"preClose":227.9,"halted":0,"volume":1542112,"delay":0,"changeRate":-0.00017551557700742448,"floatShares":110000000,"shares":110373360,"eps":9.416711,"marketStatus":"盘前交易","change":-0.04,"latestTime":"07-27 05:35:46 EDT","open":228,"high":233.2099,"low":223.42,"amount":353868903.27360004,"amplitude":0.042957,"askPrice":230,"askSize":100,"bidPrice":228.24,"bidSize":4,"shortable":3,"etf":0,"ttmEps":9.416711,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785159000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":850798800000,"exchange":"NYSE","adjPreClose":227.86,"dividendRate":0.01457,"postHourTrading":{"tag":"盘后","latestPrice":227.86,"preClose":227.86,"latestTime":"19:35 EDT","volume":21526,"amount":4904836.3,"timestamp":1784936110645,"change":0,"changeRate":0,"amplitude":0.000439},"volumeRatio":0.9562988293402227,"impliedVol":0.2748,"impliedVolPercentile":0.688},"requestUrl":"/m/hq/s/DGX","defaultTab":"news","newsList":[{"id":"1192749011","title":"异动解读 | 业绩超预期并上调全年指引,奎斯特诊疗盘中大涨11.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192749011","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192749011?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:35","pubTimestamp":1784813702,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大幅上涨11.54%,引发市场广泛关注。消息面上,公司发布2026年第二季度财报,业绩显著超出市场预期并同步上调全年指引。公司将全年调整后EPS指引上调至11.05-11.25美元,远超市场预期的10.75美元;全年营收指引上调至119.5-120.5亿美元。这已是公司连续两个季度超预期并上修全年指引,反映出诊断服务需求持续旺盛及运营效率优化成效显著,市场信心进一步增强。这些积极因素共同推动了股价的强劲上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126411757","title":"异动解读|奎斯特诊疗盘中上涨8.71%,Q2业绩大幅超预期并再度上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1126411757","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126411757?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:31","pubTimestamp":1784813499,"startTime":"0","endTime":"0","summary":"7月23日,奎斯特诊疗盘中上涨8.71%,报227.0美元/股,成交额4147.25万美元。消息面上,公司发布第二季度财报,业绩大幅超出市场预期并同步上调全年业绩指引。公司将全年调整后EPS指引上调至11.05-11.25美元区间,远超市场预期的10.75美元;全年营收指引上调至119.5-120.5亿美元,同样高于预期的118.5亿美元。这已是公司连续两个季度超预期并上修全年指引,反映出诊断服务需求持续旺盛及运营效率优化成效显著。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138583202","title":"奎斯特诊疗高管:医保定价持平至微幅增长,医院转诊业务定价略降","url":"https://stock-news.laohu8.com/highlight/detail?id=1138583202","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138583202?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:01","pubTimestamp":1784811667,"startTime":"0","endTime":"0","summary":"在业绩电话会议上,奎斯特诊疗(Quest Diagnostics)的一位高管透露:当前,健康险计划定价大体维持平稳,甚至略有上升趋势。然而,医院的转诊业务定价却呈现轻微下滑态势。这一对比,凸显了公司在不同业务板块面临的分化格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","LU0950375773.USD","BK4585","LU0823417737.USD","BK4588","LU1854103824.USD","DGX","BK4196","LU2506951875.HKD","LU2506952097.USD","LU2506951958.HKD","LU2506952170.USD","LU1854104046.USD","LU0823417653.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146159638","title":"奎斯特诊疗高管:下半年Nova支出预计占全年总额约70%,此前预期为60%——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1146159638","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146159638?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:00","pubTimestamp":1784811610,"startTime":"0","endTime":"0","summary":"奎斯特诊疗(Quest Diagnostics)的高管在电话会议中透露,预计今年下半年的Nova相关支出将占到全年总额的大约70%。这一比例较此前预期的60%有所上调,显示出公司对该项目投入节奏的调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952170.USD","LU0823417737.USD","LU0823417653.USD","BK4588","BK4567","LU2506952097.USD","DGX","LU0950375773.USD","LU2506951875.HKD","LU1854104046.USD","BK4585","BK4196","LU2506951958.HKD","LU1854103824.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133681831","title":"奎斯特诊疗高管:ACA交易业务中,医生请求数量减少,但每次请求检测量增多,两者相互抵消——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1133681831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133681831?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:55","pubTimestamp":1784811309,"startTime":"0","endTime":"0","summary":"奎斯特诊疗(Quest Diagnostics)高管在电话会议上指出,在ACA(平价医疗法案)交易所业务板块中,尽管医生发出的检测请求数量呈现下滑趋势,然而,每个请求所涵盖的检测项目数量却有所增加。这两种趋势相互抵消,使得整体业务维持相对稳定。这一动态表明,市场结构正经历微妙调整——虽然开单频次降低,但每次检测的深度或广度却有所拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506951875.HKD","BK4585","LU0823417737.USD","LU2506952097.USD","LU0950375773.USD","LU2506952170.USD","LU2506951958.HKD","BK4583","BK4567","BK4196","LU0823417653.USD","DGX","BK4588","LU1854103824.USD","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164640957","title":"异动解读|奎斯特诊疗盘前上涨6.28%,Q2财报大幅超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1164640957","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164640957?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:52","pubTimestamp":1784803949,"startTime":"0","endTime":"0","summary":"7月23日,奎斯特诊疗盘前上涨6.28%,报220.16美元/股,成交额800.71万美元。消息面上,公司发布第二季度财报,业绩大幅超出市场预期并同步上调全年业绩指引。公司同时宣布上调全年营收与每股收益指引,此前Q1财报发布时已将全年调整后EPS指引上调至10.63-10.83美元区间。连续两个季度超预期叠加指引上修,反映出诊断服务需求持续旺盛及运营效率优化成效显著,市场信心进一步增强。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"奎斯特诊疗盘前上涨6.28%,Q2财报大幅超预期并上调全年指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143294357","title":"异动解读 | 财报超预期并上调指引,奎斯特诊疗盘前大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143294357","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143294357?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:48","pubTimestamp":1784803711,"startTime":"0","endTime":"0","summary":"奎斯特诊疗(DGX)今日盘前股价大涨5.32%,表现强劲。消息面上,公司发布了2026年第二季度财务业绩,并同时宣布上调对2026年全年的营收和每股收益预期。这一积极的业绩展望增强了市场对公司未来增长潜力的信心,从而推动了股价的显著上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193577174","title":"奎斯特诊疗发布2026年第二季度财报,并上调全年营收与每股收益指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1193577174","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193577174?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:46","pubTimestamp":1784803610,"startTime":"0","endTime":"0","summary":"奎斯特诊疗公布了2026年第二季度的财务业绩,同时宣布上调对2026年全年的营收和每股收益预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU1854104046.USD","LU2506951958.HKD","LU0823417653.USD","LU2506952097.USD","DGX","BK4585","LU2506951875.HKD","LU1854103824.USD","BK4588","LU2506952170.USD","LU0950375773.USD","BK4196","LU0823417737.USD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185517081","title":"财报前瞻|奎斯特诊疗本季度营收预计增9.09%,机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1185517081","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185517081?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:19","pubTimestamp":1784164766,"startTime":"0","endTime":"0","summary":"奎斯特诊疗计划于2026年07月23日发布财报,市场关注营收与利润的同比改善及核心业务结构变化。市场一致预期本季度营收为29.73亿美元,同比增长9.09%;EBIT预计为4.88亿美元,同比增长6.83%;调整后每股收益预计为2.83美元,同比增长9.93%。公司层面关于本季度毛利率、净利润或净利率的预测未披露。近期针对奎斯特诊疗的观点呈偏积极态势,看多占比更高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|奎斯特诊疗本季度营收预计增9.09%,机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193994498","title":"Biovica再获客户订单,累计收获九份工作指令","url":"https://stock-news.laohu8.com/highlight/detail?id=1193994498","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193994498?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:15","pubTimestamp":1784013333,"startTime":"0","endTime":"0","summary":"Biovica International AB宣布,公司已从其一家领先的全球制药客户处获得了第九份工作订单。该订单总价值约为170万瑞典克朗,涵盖了测试及实验室服务等相关内容。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","LU2506951875.HKD","BK4588","LU0950375773.USD","DGX","BK4583","BK4567","LU2506952170.USD","LU0823417737.USD","LU1854104046.USD","LU0823417653.USD","LU2506951958.HKD","LU1854103824.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143761422","title":"异动解读 | 奎斯特诊疗盘中大涨5.09%,因第一季度业绩超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1143761422","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143761422?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:33","pubTimestamp":1776778385,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大涨5.09%,引起了市场的广泛关注。消息面上,公司公布了2026财年第一季度财务报告,业绩表现强劲,超出市场预期。具体来看,第一季度调整后每股收益为2.50美元,高于分析师普遍预期的2.35美元;营收达到29.0亿美元,也高于预期的28.3亿美元。公司表示,业绩增长主要得益于常规诊断检测需求的强劲复苏。基于第一季度的优异表现和对未来业务的乐观展望,奎斯特诊疗同时上调了2026全年的业绩指引。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198000730","title":"奎斯特诊疗CEO透露:60-70%资源投入实验室自动化,AI工具提升诊断准确率与呼叫中心效率","url":"https://stock-news.laohu8.com/highlight/detail?id=1198000730","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198000730?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:21","pubTimestamp":1776777674,"startTime":"0","endTime":"0","summary":"奎斯特诊疗首席执行官在电话会议中披露,公司目前将60%至70%的战略重心集中于实验室自动化领域。通过部署人工智能技术,企业不仅显著优化了诊断流程的精准度,更实现了呼叫中心运营效率的实质性跃升。这种双线并进的数字化变革,正在重塑医疗检测服务的交付模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854103824.USD","LU0823417653.USD","LU0950375773.USD","DGX","LU2506951958.HKD","BK4567","LU2506951875.HKD","LU2506952170.USD","BK4196","LU2506952097.USD","LU0823417737.USD","LU1854104046.USD","BK4583","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629039386","title":"奎斯特诊疗(DGX)盘前涨3.41% 上调2026年全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2629039386","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629039386?lang=zh_cn&edition=full","pubTime":"2026-04-21 20:04","pubTimestamp":1776773076,"startTime":"0","endTime":"0","summary":"金吾财讯 | 奎斯特诊疗(DGX)盘前股价涨3.41%,报203美元。公司公布2026年第一季度业绩,经调整每股收益2.5美元,同比增长13.1%。期内,净收入28.95美元,同比增长9.2%。展望2026年全年,公司将净收入预测由此前的117-118.2亿美元调整至117.8-119亿美元,经调整每股收益由9.45美元调整至9.58美元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299503","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2506951875.HKD","LU1854104046.USD","LU2506952170.USD","BK4583","LU0823417737.USD","BK4567","LU1854103824.USD","LU0823417653.USD","LU0950375773.USD","LU2506952097.USD","DGX","LU2506951958.HKD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168433143","title":"奎斯特诊疗公布2026财年第一季度业绩 上调全年营收与每股收益指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1168433143","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168433143?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:47","pubTimestamp":1776768437,"startTime":"0","endTime":"0","summary":"医疗诊断服务巨头奎斯特诊疗(DGX)近日发布了2026财年第一季度财务报告,业绩表现亮眼。基于强劲的季度业绩和对未来市场的乐观预期,公司同时宣布上调2026全年的营收与每股收益(EPS)财务指引。\n第一季度财务数据显示,奎斯特诊疗在营收和盈利能力方面均实现稳健增长。这一积极态势主要得益于诊断服务需求的持续回升以及公司在运营效率方面的持续优化。\n鉴于当前业务的强劲势头和有利的市场环境,管理层决定提高对2026财年整体的业绩预期。新的指引反映了公司对核心业务增长潜力的信心,同时也考虑了其在创新诊断解决方案领域的战略布局所带来的积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU2506952170.USD","BK4588","LU0823417653.USD","LU0950375773.USD","LU2506951875.HKD","DGX","LU0823417737.USD","LU2506951958.HKD","LU1854103824.USD","LU2506952097.USD","BK4196","BK4585","BK4583","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179429426","title":"财报前瞻|奎斯特诊疗本季度营收预计增7.47%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1179429426","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179429426?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:40","pubTimestamp":1776127236,"startTime":"0","endTime":"0","summary":"奎斯特诊疗将于2026年04月21日美股盘前发布最新季度财报,市场关注盈利韧性与现金回报进展。一致预期显示,本季度奎斯特诊疗营收预计为28.27亿美元,同比增长7.47%;调整后每股收益预计为2.35美元,同比增长9.16%;息税前利润预计为4.15亿美元,同比增长6.07%,公司层面的毛利率与净利率或净利润指引未见披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|奎斯特诊疗本季度营收预计增7.47%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191892993","title":"异动解读 | 奎斯特诊疗盘中大涨5.09%,受强劲财报、乐观业绩指引及股东回报措施提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1191892993","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191892993?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:39","pubTimestamp":1770734390,"startTime":"0","endTime":"0","summary":"奎斯特诊疗今日盘中大涨5.09%,引起了市场的广泛关注。消息面上,公司发布了2025年第四季度及全年财报,其营收和每股收益均超出市场预期。另一方面,公司宣布将季度股息上调7.5%至每股0.86美元,实现了连续十五年的股息增长,并同步宣布追加10亿美元的股票回购授权。这些积极的股东回报措施进一步增强了投资者信心,共同推动了股价的显著上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610207586","title":"奎斯特诊疗涨4.68% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2610207586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610207586?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:34","pubTimestamp":1770734066,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时34分,奎斯特诊疗股票出现异动,股价快速上涨4.68%。截至发稿,该股报200.20美元/股,成交量9.5785万股,换手率0.09%,振幅4.24%。奎斯特诊疗股票所在的生命科学行业中,整体跌幅为0.05%。其相关个股中,Personalis, Inc.、Precipio, Inc.、奎斯特诊疗涨幅较大,Ispecimen Inc.、Xwell, Inc.、Mainz Biomed N.V.较为活跃,换手率分别为0.73%、0.33%、0.33%,振幅较大的相关个股有Precipio, Inc.、Prenetics Global、奎斯特诊疗,振幅分别为7.22%、6.20%、4.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022342697a5a9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021022342697a5a9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4196","LU1854103824.USD","BK4583","LU0823417737.USD","LU2506952170.USD","BK4585","LU0823417653.USD","BK4567","LU2506951875.HKD","LU2506951958.HKD","LU0950375773.USD","DGX","LU1854104046.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136248766","title":"奎斯特诊疗高管确认:基于上周联邦资金法案通过,2026年PAMA将无影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1136248766","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136248766?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:50","pubTimestamp":1770731418,"startTime":"0","endTime":"0","summary":"奎斯特诊疗高管在电话会议中明确表示,随着上周联邦资金立法案的顺利通过,2026年《保护医保准入法案》将不会对公司运营产生任何影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU2506952170.USD","BK4588","LU0823417653.USD","LU0950375773.USD","LU2506951875.HKD","DGX","LU0823417737.USD","LU2506951958.HKD","LU1854103824.USD","LU2506952097.USD","BK4196","BK4585","BK4583","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127532242","title":"奎斯特诊疗公布2025年第四季度及全年财报 发布2026年度业绩指引 季度股息上调7.5%至每股0.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127532242","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127532242?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:48","pubTimestamp":1770724096,"startTime":"0","endTime":"0","summary":"奎斯特诊疗近日披露了2025年第四季度及全年财务业绩报告,同时公布了2026年全年的业绩展望。公司宣布将季度股息提高7.5%,达到每股0.86美元,展现出对股东回报的持续承诺。\n财报数据显示,公司在2025年第四季度及全年均实现了稳健的财务表现。此次股息上调反映了管理层对未来现金流生成能力的信心,以及对平衡业务增长与股东收益的战略考量。\n在2026年业绩指引中,奎斯特诊疗基于当前市场环境和业务发展趋势,提出了具体的财务目标。这一指引将为投资者评估公司未来增长潜力提供重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854103824.USD","DGX","BK4585","BK4567","LU2506951958.HKD","LU0823417737.USD","LU0823417653.USD","LU2506951875.HKD","LU2506952170.USD","BK4583","BK4588","LU0950375773.USD","BK4196","LU1854104046.USD","LU2506952097.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167905120","title":"奎斯特诊疗季度股息上调7.5%至0.86美元,实现连续十五年增长;同步宣布追加10亿美元股票回购授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1167905120","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167905120?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:33","pubTimestamp":1770723213,"startTime":"0","endTime":"0","summary":"奎斯特诊疗宣布将季度股息提高7.5%,达到每股0.86美元,这标志着该公司已实现连续十五年股息增长。与此同时,企业还公布了股票回购授权额度增加10亿美元的重大决策。股息持续上调凸显了管理层对现金流稳定性的信心,而回购计划扩容则进一步表明其致力于通过资本回报优化股东价值的战略意图。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU2506952170.USD","BK4588","LU0823417653.USD","LU0950375773.USD","LU2506951875.HKD","DGX","LU0823417737.USD","LU2506951958.HKD","LU1854103824.USD","LU2506952097.USD","BK4196","BK4585","BK4583","BK4567"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.questdiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0815},{"period":"1month","weight":0.1219},{"period":"3month","weight":0.161},{"period":"6month","weight":0.2588},{"period":"1year","weight":0.3255},{"period":"ytd","weight":0.3131}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":-0.005455},{"month":2,"riseRate":0.433333,"avgChangeRate":0.001785},{"month":3,"riseRate":0.666667,"avgChangeRate":0.019788},{"month":4,"riseRate":0.666667,"avgChangeRate":0.068015},{"month":5,"riseRate":0.733333,"avgChangeRate":0.028676},{"month":6,"riseRate":0.666667,"avgChangeRate":0.027914},{"month":7,"riseRate":0.433333,"avgChangeRate":-0.00655},{"month":8,"riseRate":0.551724,"avgChangeRate":-0.00294},{"month":9,"riseRate":0.413793,"avgChangeRate":-0.005902},{"month":10,"riseRate":0.482759,"avgChangeRate":-0.003486},{"month":11,"riseRate":0.827586,"avgChangeRate":0.033687},{"month":12,"riseRate":0.689655,"avgChangeRate":0.023389}],"exchange":"NYSE","name":"奎斯特诊疗","nameEN":"Quest Diagnostics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奎斯特诊疗,DGX,奎斯特诊疗股票,奎斯特诊疗股票老虎,奎斯特诊疗股票老虎国际,奎斯特诊疗行情,奎斯特诊疗股票行情,奎斯特诊疗股价,奎斯特诊疗股市,奎斯特诊疗股票价格,奎斯特诊疗股票交易,奎斯特诊疗股票购买,奎斯特诊疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}